Key result
PC-1 is not a true kinase; its apparent autophosphorylation reflects transient covalent adducts during its catalytic cycle, and mutation of the active-site threonine abolishes this activity.
PC-1 is not a true kinase; its autophosphorylation reflects a transient covalent adduct in its catalytic cycle, dependent on the active-site threonine.
Questions PC-1 kinase inhibition as a strategy; leaves open its catalytic role in human cardiovascular disease.
PC-1 is an ecto-enzyme possessing alkaline phosphodiesterase I (EC 3.1.4.1) and nucleotide pyrophosphatase (EC 3.6.1.9) activities. It has also been proposed to be an ecto-protein kinase capable of phosphorylating itself as well as exogenous proteins. We have investigated the phosphorylation capability of PC-1 and have developed a novel method for its detection and characterization based on autophosphorylation, which allows detection without the use of antibodies. When cells expressing membrane PC-1 were held on ice with [gamma-32P]ATP, SDS/PAGE of whole cell lysates showed a single band which was PC-1; this band was absent in cells not expressing PC-1. Immunoprecipitates of soluble PC-1 isolated from culture supernatants of cells expressing PC-1 were also capable of autophosphorylation, and the size of the labeled protein was the same as previously reported for soluble PC-1. PC-1 was also labeled with [alpha-32P]ATP and [35S]dATP[alpha S]. We found no evidence that PC-1 was capable of phosphorylating proteins other than itself, and conclude that it is not a true kinase, and that the observed labeling with [gamma-32P]ATP, [alpha-32P]ATP and [35S]dATP[alpha S] reflect transient covalent adducts that are part of the catalytic cycle of phosphodiesterase/pyrophosphatase activity rather than intrinsic kinase activity. Mutation of the active-site threonine to tyrosine, serine or alanine reduced the 5'-nucleotide phosphodiesterase activity of PC-1 and its ability to autophosphorylate to undetectable levels. Together, these data suggest that both activities depend on the same site.
No takes yet. Share an insight, caveat, or question.
Belli et al. (1995) studied this question. Mutation of the active-site threonine vs. Wild-type PC-1 was evaluated on 5'-nucleotide phosphodiesterase activity and autophosphorylation capability. PC-1 is not a true kinase; its apparent autophosphorylation reflects transient covalent adducts during its catalytic cycle, and mutation of the active-site threonine abolishes this activity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: